BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion ( MTAP -del): Exploratory pharmacodynamic (PD) and biomarker analyses from CA240-0007.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jason Timothy Henry, Deepak Perumal, Jordi Rodon Ahnert, Ben George, Pasi A. Jänne, Konstantinos Leventakos, Kathryn C. Arbour, Melissa Lynne Johnson, Kyriakos Papadopoulos, Candace L. Haddox, Alexander I. Spira, Cesar Augusto Perez, Hani M. Babiker, Richard Zuniga, Mandana Kamgar, Yidi Qin, Tapsi Kumar, Amy Hung, Mena Abaskharoun, Ming Lei
Institutions: HealthONE, Bristol-Myers Squibb (United States), The University of Texas MD Anderson Cancer Center, Mayo Clinic, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Sarah Cannon, South Texas Accelerated Research Therapeutics, Virginia Cancer Specialists, Mayo Clinic in Florida, Medical College of Wisconsin
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162531694
Cites:
Cited by:
Related to: